Literature DB >> 7239320

Distribution of prostaglandins in gastric and duodenal mucosa of healthy subjects and duodenal ulcer patients: effects of aspirin and paracetamol.

S J Konturek, W Obtulowicz, E Sito, J Oleksy, S Wilkon, A Kiec-Dembinska.   

Abstract

The distribution of mucosal PGE2-like activity was determined by bioassay technique in the body and antrum of the stomach and in the duodenum of healthy subjects and duodenal ulcer patients before and after administration of aspirin, paracetamol, or histamine. In healthy subjects, the oxyntic, antral and duodenal mucosa was found to be capable of generating large amounts of PGE2, which were not significantly different from those found in duodenal ulcer patients. No correlation was found between the generation of PGE2 and gastric acid secretory status or serum gastrin level. Aspirin-and to a much lesser extent, paracetamol-caused a dramatic reduction in the ability of the gastric mucosa to biosynthesis PGE2 and this was accompanied by marked side-effects and injury to the gastric mucosa. Administration of histamine caused small but significant reduction in the biosynthesis of PGE2 but it was accompanied by marked mucosal damage. This study indicates that the gastric and duodenal mucosa is capable of generating PGE2-like activity which may be involved in the mechanism that protects the mucosa against the damage caused by aspirin.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7239320      PMCID: PMC1419145          DOI: 10.1136/gut.22.4.283

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1964-10

2.  Potential endogenous inhibitor of prostaglandin synthetase in plasma: failure to inhibit cyclo-oxygenase in platelets and the gastric mucosa.

Authors:  B J Whittle
Journal:  J Pharm Pharmacol       Date:  1978-07       Impact factor: 3.765

3.  Gastric prostaglandin E output during basal and stimulated acid secretion in normal subjects and patients with duodenal ulcer.

Authors:  L Y Cheung; W Jubiz; J G Moore
Journal:  J Surg Res       Date:  1976-04       Impact factor: 2.192

Review 4.  Hypotheses on physiological roles of prostaglandins.

Authors:  E W Horton
Journal:  Physiol Rev       Date:  1969-01       Impact factor: 37.312

5.  Prostaglandin E in peptic ulcer disease.

Authors:  J G Hinsdale; J J Engel; D E Wilson
Journal:  Prostaglandins       Date:  1974-06-25

6.  Aspirin selectively inhibits prostaglandin production in human platelets.

Authors:  J B Smith; A L Willis
Journal:  Nat New Biol       Date:  1971-06-23

7.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

8.  Inactivation of prostaglandins by the lungs.

Authors:  P J Piper; J R Vane; J H Wyllie
Journal:  Nature       Date:  1970-02-14       Impact factor: 49.962

9.  Prostaglandin E2 and gastric acid secretion in man.

Authors:  A Bennett; I F Stamford; W G Unger
Journal:  J Physiol       Date:  1973-03       Impact factor: 5.182

10.  Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides.

Authors:  R J Gryglewski; S Bunting; S Moncada; R J Flower; J R Vane
Journal:  Prostaglandins       Date:  1976-11
View more
  17 in total

1.  Healing of acetic acid-induced gastric ulcer and gastric mucosal PGI2 level in rats.

Authors:  M Uchida; O Kawano; N Misaki; K Saitoh; O Irino
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

2.  Indomethacin treatment during initial period of acetic acid-induced rat gastric ulcer healing promotes persistent polymorphonuclear cell-infiltration and increases future ulcer recurrence. Possible mediation of prostaglandins.

Authors:  T Arakawa; T Watanabe; T Fukuda; K Higuchi; O Takaishi; K Yamasaki; K Kobayashi; A Tarnawski
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

Review 3.  Etodolac. A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states.

Authors:  J A Balfour; M M Buckley
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

4.  Prevention of ethanol and aspirin-induced gastric mucosal lesions by paracetamol and salicylate in rats: role of endogenous prostaglandins.

Authors:  S J Konturek; T Brzozowski; I Piastucki; T Radecki
Journal:  Gut       Date:  1982-06       Impact factor: 23.059

5.  Environmental factors in aetiology of chronic gastric ulcer: a case control study of exposure variables before the first symptoms.

Authors:  J H McIntosh; K Byth; D W Piper
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

Review 6.  Gastrointestinal intolerance and bleeding with non-narcotic analgesics.

Authors:  K J Ivey
Journal:  Drugs       Date:  1986       Impact factor: 9.546

7.  Sample taking problems in measuring actual histamine levels of human gastroduodenal mucosa: specific and general relevance in clinical trials on peptic ulcer pathogenesis and selective proximal vagotomy.

Authors:  K P Thon; W Lorenz; C Ohmann; D Weber; H Rohde; H D Röher
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

8.  Prostaglandins in pathophysiology of peptic ulcer disease.

Authors:  S J Konturek
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

9.  Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man.

Authors:  S J Konturek; N Kwiecień; W Obtułowicz; M Polański; B Kopp; J Oleksy
Journal:  Gut       Date:  1983-02       Impact factor: 23.059

10.  The effect of tiaprofenic acid and indomethacin on in vitro prostaglandin synthesis by rat, rabbit and human stomach tissue.

Authors:  J Y Jeremy; D P Mikhailidis; P Dandona
Journal:  Agents Actions       Date:  1985-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.